你目前无法使用部分二次筛选功能
请联系客服开通更多权限和功能！
| UNII号(唯一标识码) | 辅料名称 | CAS号 | 给药途径 | 剂型 | 最大用量 | 历史数据 |
|---|---|---|---|---|---|---|
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | TABLET, FOR SUSPENSION | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | CAPSULE, EXTENDED RELEASE | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | BUCCAL | FILM, EXTENDED RELEASE | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | TABLET | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | LOZENGE | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | SUBLINGUAL | TABLET | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | SYRUP | 0.63mg/5ml | 查看 |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | TABLET, CHEWABLE | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | POWDER, FOR SOLUTION | 233mg | 查看 |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | SUSPENSION | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | TABLET, FILM COATED | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | POWDER, FOR SUSPENSION | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | GRANULE, FOR SUSPENSION | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | GRANULE, EFFERVESCENT | 30mg | 查看 |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | TABLET, ORALLY DISINTEGRATING | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | SOLUTION | 查看 | |
| Z0H242BBR1 | ASPARTAME | 22839-47-0 | ORAL | POWDER | 查看 |
